h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
IISHDOi003-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
IISHDOi003-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
IISHDOi003-A (RRID:CVCL_QX87)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
27th July 2017
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Instituto de Investigación Sanitaria Hospital 12 de Octubre, i+12 (IISHDO)
External Databases
Cellosaurus
CVCL_QX87
Wikidata
Q54897447
General Information
Publications
Zurita-Díaz F et al. Establishment of a human DOA 'plus' iPSC line, IISHDOi003-A, with the mutation in the OPA1 gene: c.1635C>A; p.Ser545Arg. Stem cell research. 2017 Oct;24:81-84.
Del Dotto V et al. Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis. Frontiers in neurology. 2021;12:681326.
García-López M et al. Hereditary Optic Neuropathies: Induced Pluripotent Stem Cell-Based 2D/3D Approaches. Genes. 2021 Jan 18;12(1).
McKnight CL et al. Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?. International journal of molecular sciences. 2021 Jul 20;22(14).
Kang EY et al. Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration. Antioxidants (Basel, Switzerland). 2021 Dec 5;10(12).
Harvey JP et al. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2022 Mar 1;42(1):35-44.
Sladen Paul E et al. Modelling autosomal dominant optic atrophy associated with
OPA1
variants in iPSC-derived retinal ganglion cells. Human Molecular Genetics. 2022-10-10.
Pohl Katherine A. et al. Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct OPA1 mutations and clinical pathologies. Frontiers in Genetics. 2023-09-04.
Ladero Miguel et al. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells. Bioengineering. 2024-01-03.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.